Mahkam Zanganeh, CEO: Summit Therapeutics SMMT Buy · Filed 24/03/27

Trade details

Type: Insider buy
Amount: $127,674.12
Shares · price: 34,321 sh · $3.72 a share
Held after: 24,923,800 sh
Stock: Summit Therapeutics SMMT
Person: Mahkam ZanganehCEO
Trade date: 24/03/27
Filed: 24/03/27
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +0.1%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/26~24/04/26

Mahkam Zanganeh's recent trades

Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$50M
3,810,000 sh
$50M
Filed 06/12
Traded 06/12
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$500K
26,680 sh
$500K
Filed 25/10/23
Traded 25/10/21
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$5.9M
333,394 sh
$5.9M
Filed 25/09/11
Traded 25/09/10
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$90.4K
5,000 sh
$90.4K
Filed 25/09/11
Traded 25/09/11

Mahkam Zanganeh, CEO — bought $127.7K of Summit Therapeutics SMMT · 34,321 sh @ $3.72 | Whalegun